123 related articles for article (PubMed ID: 6324812)
41. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
42. A unitary mechanism of calcium antagonist drug action.
Murphy KM; Gould RJ; Largent BL; Snyder SH
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):860-4. PubMed ID: 6572372
[TBL] [Abstract][Full Text] [Related]
43. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.
Bean BP
Proc Natl Acad Sci U S A; 1984 Oct; 81(20):6388-92. PubMed ID: 6093100
[TBL] [Abstract][Full Text] [Related]
44. Calcium-channel antagonist binding to isolated vascular smooth muscle membranes.
Triggle CR; Agrawal DK; Bolger GT; Daniel EE; Kwan CY; Luchowski EM; Triggle DJ
Can J Physiol Pharmacol; 1982 Dec; 60(12):1738-41. PubMed ID: 7165866
[TBL] [Abstract][Full Text] [Related]
45. The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats.
Ehlert FJ; Itoga E; Roeske WR; Yamamura HI
Biochem Biophys Res Commun; 1982 Feb; 104(3):937-43. PubMed ID: 7073736
[No Abstract] [Full Text] [Related]
46. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
47. Binding of a calcium antagonist, [3H]nitrendipine, to high affinity sites in bovine aortic smooth muscle and canine cardiac membranes.
Williams LT; Tremble P
J Clin Invest; 1982 Jul; 70(1):209-12. PubMed ID: 6282938
[TBL] [Abstract][Full Text] [Related]
48. Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
Psychoyos S; Bax M; Atkins C
Biochem Pharmacol; 1986 May; 35(10):1639-46. PubMed ID: 3011009
[TBL] [Abstract][Full Text] [Related]
49. Differential sensitivity of [3H]nitrendipine binding to cations of toxicological interest in various rat brain areas.
Rius RA; Govoni S; Battaini F; Trabucchi M
Toxicol Lett; 1985 Sep; 27(1-3):103-8. PubMed ID: 2414865
[TBL] [Abstract][Full Text] [Related]
50. Atrotoxin: a specific agonist for calcium currents in heart.
Hamilton SL; Yatani A; Hawkes MJ; Redding K; Brown AM
Science; 1985 Jul; 229(4709):182-4. PubMed ID: 3160111
[TBL] [Abstract][Full Text] [Related]
51. Allosteric interaction of trimebutine maleate with dihydropyridine binding sites.
Nagasaki M; Kurosawa H; Naito K; Tamaki H
Eur J Pharmacol; 1990 Jul; 189(1):71-6. PubMed ID: 2171963
[TBL] [Abstract][Full Text] [Related]
52. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
Schoemaker H; Boles RG; Roeske WR; Yamamura HI
Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
[No Abstract] [Full Text] [Related]
53. [3H]nitrendipine-labeled calcium channels discriminate inorganic calcium agonists and antagonists.
Gould RJ; Murphy KM; Snyder SH
Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3656-60. PubMed ID: 6285357
[TBL] [Abstract][Full Text] [Related]
54. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences.
Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN
Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284
[TBL] [Abstract][Full Text] [Related]
55. Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
Spedding M; Mir AK
Br J Pharmacol; 1987 Oct; 92(2):457-68. PubMed ID: 2445406
[TBL] [Abstract][Full Text] [Related]
56. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
57. Subcellular localization of [3H]-nitrendipine binding sites in guinea-pig ileal smooth muscle.
Godfraind T; Wibo M
Br J Pharmacol; 1985 Jun; 85(2):335-40. PubMed ID: 2992659
[TBL] [Abstract][Full Text] [Related]
58. A simple sensitive radioreceptor assay for calcium antagonist drugs.
Gould RJ; Murphy KM; Snyder SH
Life Sci; 1983 Dec; 33(26):2665-72. PubMed ID: 6319847
[TBL] [Abstract][Full Text] [Related]
59. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.
Zernig G; Graziadei I; Moshammer T; Zech C; Reider N; Glossmann H
Mol Pharmacol; 1990 Sep; 38(3):362-9. PubMed ID: 1698252
[TBL] [Abstract][Full Text] [Related]
60. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
